Savaysa vs. Lovenox

See how Savaysa and Lovenox compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Savaysa is a once-daily pill for stroke prevention in atrial fibrillation and for treating blood clots, while Lovenox is an injectable used mainly for short-term clot prevention after surgery or a heart attack.

  • Both drugs raise bleeding risk, but Savaysa carries a boxed warning against use in atrial fibrillation patients whose kidneys work very well.

  • Lovenox is generally far less expensive than Savaysa, though it requires self-injection instead of a swallowed tablet.

Savaysa vs. Lovenox Drug Summary

Savaysa

Savaysa (edoxaban) is a factor Xa inhibitor, an oral anticoagulant that lowers stroke risk in people with nonvalvular atrial fibrillation and treats deep vein thrombosis (DVT) and pulmonary embolism (PE). It comes as a tablet taken once a day, with the dose adjusted for kidney function and body weight.

Lovenox

Lovenox (enoxaparin) is a low molecular weight heparin, an injectable anticoagulant used to prevent and treat blood clots such as DVT and PE, and to help prevent complications during certain heart attacks. It is given as a subcutaneous injection, with dosing and frequency depending on the reason it is prescribed.

Savaysa vs. Lovenox Side Effects

Savaysa

Most common
Bleeding (any) (up to 21.7%)
Clinically-relevant non-major bleeding (up to 18.1%)
Anemia (up to 9.6%)
Abnormal liver function tests (up to 4.8%)

Lovenox

Most common
Anemia (up to 16%)
Hemorrhage (up to 13%)
Fever (up to 8%)
Peripheral edema (up to 6%)

Savaysa vs. Lovenox Dosage

Savaysa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 60 mg once daily At the start
Maximum dose 30 mg once daily If needed
Dose changes 1 increase As tolerated

Lovenox

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 30 mg every 12 hours At the start
Maximum dose 30 mg IV bolus once If needed
Dose changes 3 increases As tolerated

Savaysa vs. Lovenox Indications

Savaysa

Savaysa is FDA-approved to lower the risk of stroke and blood clots in people with nonvalvular atrial fibrillation, and to treat DVT and PE after an initial period on an injectable blood thinner. It is not approved for people with mechanical heart valves or antiphospholipid syndrome.

  • Reduce stroke and systemic embolism risk in nonvalvular atrial fibrillation

  • Treatment of deep vein thrombosis (DVT)

  • Treatment of pulmonary embolism (PE)

Lovenox

Lovenox is FDA-approved to prevent DVT after hip, knee, or abdominal surgery, and in certain medical patients at risk for clots. It also treats existing DVT and PE, and is used with aspirin for unstable angina and heart attacks including STEMI.

  • DVT prevention after hip or knee replacement surgery

  • DVT prevention after abdominal surgery

  • Treatment of DVT and PE

Savaysa vs. Lovenox Pros and Cons

Savaysa

Savaysa offers simple once-daily oral dosing without routine blood monitoring, but it carries a boxed warning limiting its use in atrial fibrillation patients with very good kidney function. It also needs several days of injectable anticoagulant before it can be started for a new DVT or PE.

Pros

  • Taken as a pill once a day, no injections

  • No routine blood monitoring required

  • One dose reduction covers both renal and weight adjustments

Cons

  • Boxed warning: not for AF patients with CrCL over 95 mL/min

  • Needs 5 to 10 days of injectable anticoagulant first for DVT/PE

  • Typically $483 to $561 per month, more than generic enoxaparin

Lovenox

Lovenox works right away without a lead-in drug and has decades of use across surgical and cardiac care, but it must be injected rather than swallowed. It carries its own boxed warning about spinal or epidural bleeding during certain procedures.

Pros

  • No lead-in anticoagulant needed before starting

  • Generic enoxaparin often costs $30 to $150 a month, well below Savaysa

  • Long track record in surgery and heart attack care

Cons

  • Requires self-injection, often twice a day

  • Boxed warning for spinal or epidural hematoma risk

  • Not approved for long-term stroke prevention in atrial fibrillation

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.